Leadership in Biotech

Tag: ai agent

Illustration of a desk with a figure from a recent paper about the Kosmos AI agent

Kosmos and the Culture of Discovery

AI Scientists are all the rage these days, and that excitement ramped up a notch or ten this week with the announcements of the Kosmos preprint from prominent AI researchers (notably, FutureHouse). The Kosmos system takes on an ambitious question:

Can an AI not only assist with science, but do science on its own?

Designed to read literature, analyze data, and generate new hypotheses in 12-hour autonomous runs, Kosmos reports nearly 80% statement accuracy and the equivalent of six months of human research per cycle.

It’s an extraordinary technical achievement…

…and…

…one that forces us to ask what, exactly, counts as scientific discovery?

Scientific Insight

At its core, Kosmos is a multi-agent system. One agent searches the literature, another analyzes data, and a coordinating model stitches their findings together into a cohesive research narrative.

The architecture is impressive and elegant, but it also reveals a key limitation.

Kosmos optimizes for coherence—for ideas that fit neatly together—rather than for falsifiability or experimental test.

The result is a system that can produce consistent and compelling stories, but not yet the self-correcting friction that turns a story into durable scientific insight.

Leadership Angle

For those of us leading R&D organizations, Kosmos is both inspiring and instructive. It shows how far autonomous reasoning has come. And it also demonstrates how easily coherence can masquerade as progress.

In the context of industrial scientific research, this lesson feels particularly relevant. Our job isn’t to chase automation for its own sake (although driving down cost is certainly a constant imperative), it’s to develop products that are safe, effective, and hold up in the real world.

To accomplish this task, we need to design scientific teams where human judgment and machine synthesis elevate the best of what each brings to the table.

Our new AI teammate is here, and in order to figure out how to integrate them safely and effectively with your human team, learning to manage them effectively is absolutely critical.

Mentorship Angle

For early-career scientists, Kosmos highlights part of what the future of science will look like, so pay attention to what these AI ‘scientists’ can and cannot deliver, and how they evolve.

Right now, Kosmos is fast, thorough, and tireless, but optimized to find coherence. The craft of science still lives in that space of productive stupidity and intellectual humility: the messy, uncertain, human part where you argue with data (and with your fellow scientists), question assumptions, and let yourself be wrong. AI can’t automate that part (at least not yet).

If Kosmos points to a future of machine collaborators, then the most valuable skill you can build now is learning how to think with them—and sometimes, against them.

Illustration of a desk with a figure from a paper on ChatNT

ChatNT: The future of biological assistants—or a mirage in a lab coat?

The team behind ChatNT introduces a conversational AI agent trained to perform 27 genomics, transcriptomics, and proteomics tasks—by prompting it in plain English. Built on a DNA encoder (Nucleotide Transformer v2) and a frozen English decoder (Vicuna-7B), ChatNT achieves state-of-the-art or near-parity performance with many specialized models, solving tasks like splice site detection, RNA degradation prediction, and protein melting point estimation—all through natural language queries.

But before we celebrate too loudly…

What does it mean when we start predicting complex molecular properties by chatting with a model—and trusting the answer without understanding the underlying biology? ChatNT lowers the barrier to entry, making powerful models accessible to those without deep bioinformatics expertise. That’s a design strength—but also a risk. Scientific depth, if not deliberately preserved, can quietly erode. We could end up with users who can write reasonable prompts but lack the scientific grounding to recognize when the answers are wrong or incomplete, and don’t have the foundational knowledge needed for scientific creativity.

To their credit, the authors do include a post hoc, perplexity-based calibration method to understand the model’s confidence in its answer (in other words, they check how confidently the model would have chosen its answer by measuring how surprised it is by different options after the fact). But there’s no real-time uncertainty alert, no embedded safeguard for when the model is operating outside its training distribution—just statistical proxies layered onto a system that still speaks with unwarranted certainty. In regulated or high-stakes domains like diagnostics, that’s absolutely not enough. Hallucinations don’t come with warning labels. And a well-attributed motif—say, a TATA box or splice site—is no guarantee of biological correctness.

From a diagnostics strategy perspective, ChatNT is a credible preview of what’s coming: a unified interface for interpreting multi-omics data and compressing complex workflows into a single prompt. But we are not there yet. Trust, fidelity, and epistemic transparency remain unsolved. For now, these models should be treated as useful but fallible junior collaborators—not autonomous copilot researchers in their own right.

To early-career scientists: this is your edge. Tools like ChatNT are remarkable—but only in the hands of those who still understand the biology. The future still belongs to those who can spot an implausible claim, who know how to interrogate things from first principles, and who can still deploy their own knowledge to connect disparate dots and generate novel scientific hypotheses. Your role isn’t to step aside. It’s to double down on understanding, so that you can interrogate, shape, and lead the evolution of these tools.

How I’d want my team to use this tool: Use ChatNT to validate hypotheses you’ve already reasoned through—not to generate them in isolation. Let it help challenge assumptions, spot inconsistencies, or simulate mechanistic alternatives based on sequence features. Think of it as a fast, articulate assistant: useful for in-silico hypothesis exploration, not for making experimental decisions without expert oversight. And never input PHI or proprietary data into public-facing AI tools. Period.

Powered by WordPress & Theme by Anders Norén